A 2019 clip of Kamala Harris discussing the seizure of drug patents is linked to the Biden administration's 2023 "March-in rights" policy. This policy allows the government to seize patents for medicines developed with federal funding if prices are deemed too high. It is noted that the intelligence community has historically suppressed patents for national security reasons without public challenge.
